1. Home
  2. IPI vs TRVI Comparison

IPI vs TRVI Comparison

Compare IPI & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPI
  • TRVI
  • Stock Information
  • Founded
  • IPI 2000
  • TRVI 2011
  • Country
  • IPI United States
  • TRVI United States
  • Employees
  • IPI N/A
  • TRVI N/A
  • Industry
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • TRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPI Industrials
  • TRVI Health Care
  • Exchange
  • IPI Nasdaq
  • TRVI Nasdaq
  • Market Cap
  • IPI 288.5M
  • TRVI 341.4M
  • IPO Year
  • IPI 2008
  • TRVI 2019
  • Fundamental
  • Price
  • IPI $27.18
  • TRVI $3.56
  • Analyst Decision
  • IPI Sell
  • TRVI Strong Buy
  • Analyst Count
  • IPI 2
  • TRVI 8
  • Target Price
  • IPI $21.00
  • TRVI $9.31
  • AVG Volume (30 Days)
  • IPI 121.4K
  • TRVI 659.4K
  • Earning Date
  • IPI 03-05-2025
  • TRVI 03-19-2025
  • Dividend Yield
  • IPI N/A
  • TRVI N/A
  • EPS Growth
  • IPI N/A
  • TRVI N/A
  • EPS
  • IPI N/A
  • TRVI N/A
  • Revenue
  • IPI $206,359,000.00
  • TRVI N/A
  • Revenue This Year
  • IPI N/A
  • TRVI N/A
  • Revenue Next Year
  • IPI $3.40
  • TRVI N/A
  • P/E Ratio
  • IPI N/A
  • TRVI N/A
  • Revenue Growth
  • IPI N/A
  • TRVI N/A
  • 52 Week Low
  • IPI $17.52
  • TRVI $1.30
  • 52 Week High
  • IPI $29.75
  • TRVI $4.68
  • Technical
  • Relative Strength Index (RSI)
  • IPI 65.09
  • TRVI 43.13
  • Support Level
  • IPI $26.23
  • TRVI $3.63
  • Resistance Level
  • IPI $27.79
  • TRVI $4.06
  • Average True Range (ATR)
  • IPI 1.12
  • TRVI 0.30
  • MACD
  • IPI 0.64
  • TRVI -0.11
  • Stochastic Oscillator
  • IPI 91.13
  • TRVI 0.44

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: